(Reuters) -GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science. Mark Cheffo, a lawyer for GSK, told Judge Vivian Medinilla of the Delaware Superior Court in Wilmington that the litigation was "a case of lawyers and lawsuits getting ahead of the science - way, way ahead of the science," at
GSK, Pfizer and other
pharmaceutical companies are urging a judge in Delaware this
week to find that evidence plaintiffs lawyers want to use in
about 72,000 lawsuits claiming that the discontinued.
Tens of thousands of lawsuits have their origins in a man once arrested after firing a gun into the ceiling of his Yale University frat house and threatening a visitor, resulting in police discovering an illegal arsenal of weapons and explosives that earned him a one-year prison sentence.